Cyclenium Pharma Inc.
Contact: Mark Peterson
7171 rue Frederick Banting
About Cyclenium Pharma Inc.
Cyclenium Pharma is an emerging, privately-held pharmaceutical R&D company exploiting its proprietary CMRT™ macrocyclic technology for the discovery and development of novel small molecule therapeutic agents to address areas of unsatisfied medical need.
Cyclenium is creating value through progression of internal programs in oncology, infectious diseases and inflammation/pain. In addition, Cyclenium is providing its extensive experience and exploring its CMRT-based QUEST™ screening library in risk-sharing partnerships with leading academic and research driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies world-wide seeking to modulate unique and difficult disease targets in diverse therapeutic areas.
As CYclenium enters a growth phase in its company development, we are seeking innovative, talented and committed scientists at the M.S. and Ph.D. levels with experience in organic, medicinal and analytical chemistry to join our expanding research team.
1 job with Cyclenium Pharma Inc.
Hands-on drug discovery position responsible for the design and execution of synthetic routes to novel small molecules and their components.